Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13850 | 809 | 31.8 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
51 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD | 91443 |
128 | 2 | BONE MARROW TRANSPLANTATION//HEMATOLOGY//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 23958 |
13850 | 1 | BUSULFAN//TREOSULFAN//BU | 809 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BUSULFAN | authKW | 4407394 | 30% | 48% | 245 |
2 | TREOSULFAN | authKW | 902068 | 5% | 54% | 44 |
3 | BU | authKW | 345067 | 2% | 57% | 16 |
4 | INTRAVENOUS BUSULFAN | authKW | 289925 | 2% | 59% | 13 |
5 | IV BUSULFAN | authKW | 226459 | 1% | 100% | 6 |
6 | BUSULPHAN | authKW | 218347 | 2% | 32% | 18 |
7 | CONDITIONING REGIMEN | authKW | 154738 | 3% | 18% | 23 |
8 | BONE MARROW TRANSPLANTATION | journal | 153819 | 23% | 2% | 189 |
9 | HEPSULFAM | authKW | 120776 | 0% | 80% | 4 |
10 | LIPOSOMAL BUSULPHAN | authKW | 113229 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Transplantation | 24061 | 36% | 0% | 290 |
2 | Hematology | 23250 | 51% | 0% | 416 |
3 | Oncology | 6868 | 48% | 0% | 386 |
4 | Immunology | 3991 | 34% | 0% | 277 |
5 | Pharmacology & Pharmacy | 815 | 20% | 0% | 165 |
6 | Medical Laboratory Technology | 435 | 4% | 0% | 33 |
7 | Toxicology | 84 | 4% | 0% | 31 |
8 | Chemistry, Analytical | 67 | 5% | 0% | 44 |
9 | Pediatrics | 58 | 4% | 0% | 32 |
10 | Biochemical Research Methods | 28 | 3% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ALBERTA BLOOD MARROW TRANSPLANT PROGRAM | 94353 | 1% | 50% | 5 |
2 | CHILDRENS HSCT UNIT | 75486 | 0% | 100% | 2 |
3 | PHYS PHARM PHARMACOKINET | 65223 | 1% | 16% | 11 |
4 | CHARLES BRUNEAU CANC | 61636 | 1% | 23% | 7 |
5 | CANSEARCH | 54894 | 0% | 36% | 4 |
6 | PHARMACEUT MED CHEM CLIN PHARM | 54894 | 0% | 36% | 4 |
7 | UNIV HEMATOL BMT | 50323 | 0% | 67% | 2 |
8 | ACUTE LEUKAEMIA WORKING COMM | 37743 | 0% | 100% | 1 |
9 | ANALYT CHEMMINATO KU | 37743 | 0% | 100% | 1 |
10 | BLOOD DIS HOSPPEKING UNION | 37743 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BONE MARROW TRANSPLANTATION | 153819 | 23% | 2% | 189 |
2 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 62613 | 9% | 2% | 71 |
3 | THERAPEUTIC DRUG MONITORING | 6798 | 3% | 1% | 26 |
4 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 5229 | 4% | 0% | 32 |
5 | LANCET HAEMATOLOGY | 1434 | 0% | 2% | 2 |
6 | BLOOD | 1297 | 4% | 0% | 35 |
7 | PEDIATRIC TRANSPLANTATION | 1040 | 1% | 0% | 8 |
8 | JAPANESE JOURNAL OF TRANSPLANTATION | 983 | 0% | 1% | 2 |
9 | ANNALS OF HEMATOLOGY | 818 | 1% | 0% | 9 |
10 | INTERNATIONAL JOURNAL OF HEMATOLOGY | 796 | 1% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BUSULFAN | 4407394 | 30% | 48% | 245 | Search BUSULFAN | Search BUSULFAN |
2 | TREOSULFAN | 902068 | 5% | 54% | 44 | Search TREOSULFAN | Search TREOSULFAN |
3 | BU | 345067 | 2% | 57% | 16 | Search BU | Search BU |
4 | INTRAVENOUS BUSULFAN | 289925 | 2% | 59% | 13 | Search INTRAVENOUS+BUSULFAN | Search INTRAVENOUS+BUSULFAN |
5 | IV BUSULFAN | 226459 | 1% | 100% | 6 | Search IV+BUSULFAN | Search IV+BUSULFAN |
6 | BUSULPHAN | 218347 | 2% | 32% | 18 | Search BUSULPHAN | Search BUSULPHAN |
7 | CONDITIONING REGIMEN | 154738 | 3% | 18% | 23 | Search CONDITIONING+REGIMEN | Search CONDITIONING+REGIMEN |
8 | HEPSULFAM | 120776 | 0% | 80% | 4 | Search HEPSULFAM | Search HEPSULFAM |
9 | LIPOSOMAL BUSULPHAN | 113229 | 0% | 100% | 3 | Search LIPOSOMAL+BUSULPHAN | Search LIPOSOMAL+BUSULPHAN |
10 | SINGLE DOSE DAILY REGIMEN | 113229 | 0% | 100% | 3 | Search SINGLE+DOSE+DAILY+REGIMEN | Search SINGLE+DOSE+DAILY+REGIMEN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RUSSELL, JA , KANGARLOO, SB , (2008) THERAPEUTIC DRUG MONITORING OF BUSULFAN IN TRANSPLANTATION.CURRENT PHARMACEUTICAL DESIGN. VOL. 14. ISSUE 20. P. 1936-1949 | 126 | 85% | 36 |
2 | GALAUP, A , PACI, A , (2013) PHARMACOLOGY OF DIMETHANESULFONATE ALKYLATING AGENTS: BUSULFAN AND TREOSULFAN.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 9. ISSUE 3. P. 333-347 | 90 | 83% | 10 |
3 | PALMER, J , MCCUNE, JS , PERALES, MA , MARKS, D , BUBALO, J , MOHTY, M , WINGARD, JR , PACI, A , HASSAN, M , BREDESON, C , ET AL (2016) PERSONALIZING BUSULFAN-BASED CONDITIONING: CONSIDERATIONS FROM THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION PRACTICE GUIDELINES COMMITTEE.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 22. ISSUE 11. P. 1915 -1925 | 83 | 85% | 0 |
4 | MCCUNE, JS , HOLMBERG, LA , (2009) BUSULFAN IN HEMATOPOIETIC STEM CELL TRANSPLANT SETTING.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 5. ISSUE 8. P. 957-969 | 71 | 81% | 32 |
5 | TEN BRINK, MH , ZWAVELING, J , SWEN, JJ , BREDIUS, RGM , LANKESTER, AC , GUCHELAAR, HJ , (2014) PERSONALIZED BUSULFAN AND TREOSULFAN CONDITIONING FOR PEDIATRIC STEM CELL TRANSPLANTATION: THE ROLE OF PHARMACOGENETICS AND PHARMACOKINETICS.DRUG DISCOVERY TODAY. VOL. 19. ISSUE 10. P. 1572 -1586 | 68 | 77% | 5 |
6 | CIUREA, SO , ANDERSSON, BS , (2009) BUSULFAN IN HEMATOPOIETIC STEM CELL TRANSPLANTATION.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 15. ISSUE 5. P. 523-536 | 69 | 72% | 67 |
7 | HUEZO-DIAZ, P , UPPUGUNDURI, CRS , TYAGI, AK , KRAJINOVIC, M , ANSARI, M , (2014) PHARMACOGENETIC ASPECTS OF DRUG METABOLIZING ENZYMES IN BUSULFAN BASED CONDITIONING PRIOR TO ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN.CURRENT DRUG METABOLISM. VOL. 15. ISSUE 3. P. 251 -264 | 70 | 64% | 2 |
8 | ANSARI, M , THEORET, Y , REZGUI, MA , PETERS, C , MEZZIANI, S , DESJEAN, C , VACHON, MF , CHAMPAGNE, MA , DUVAL, M , KRAJINOVIC, M , ET AL (2014) ASSOCIATION BETWEEN BUSULFAN EXPOSURE AND OUTCOME IN CHILDREN RECEIVING INTRAVENOUS BUSULFAN BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION.THERAPEUTIC DRUG MONITORING. VOL. 36. ISSUE 1. P. 93-99 | 44 | 94% | 8 |
9 | TESFAYE, H , BRANOVA, R , KLAPKOVA, E , PRUSA, R , JANECKOVA, D , RIHA, P , SEDLACEK, P , KESLOVA, P , MALIS, J , (2014) THE IMPORTANCE OF THERAPEUTIC DRUG MONITORING (TDM) FOR PARENTERAL BUSULFAN DOSING IN CONDITIONING REGIMEN FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN CHILDREN.ANNALS OF TRANSPLANTATION. VOL. 19. ISSUE . P. 214 -224 | 46 | 88% | 3 |
10 | TSE, WT , DUERST, R , SCHNEIDERMAN, J , CHAUDHURY, S , JACOBSOHN, D , KLETZEL, M , (2009) AGE-DEPENDENT PHARMACOKINETIC PROFILE OF SINGLE DAILY DOSE I.V. BUSULFAN IN CHILDREN UNDERGOING REDUCED-INTENSITY CONDITIONING STEM CELL TRANSPLANT.BONE MARROW TRANSPLANTATION. VOL. 44. ISSUE 3. P. 145 -156 | 42 | 95% | 15 |
Classes with closest relation at Level 1 |